COVID-19

SARS-CoV-2 was detectable in aerosols for up to 3 hours, up to 4 hours on copper, up to 24 hours on cardboard, and up to 3 days on plastic and stainless steel.

The availability of personal protective equipment, including face masks, gloves and hand sanitizers, have been a concern to many pharmacists.

Pharmacy giants Walgreens and CVS are taking extensive steps to ensure patient access to medications during the novel coronavirus (COVID-19) pandemic, including waiving drug delivery fees and expanding telehealth options.

The FDA acknowledged that protocol modifications or deviations may be required for clinical trials during the COVID-19 pandemic.

The approval allows Florida to waive certain requirements in Medicare, Medicaid, and CHIP.

Researchers and senior physicians support a French official’s warning that individuals showing symptoms of the novel coronavirus should use paracetamol rather than ibuprofen.

Some pharmacists and technicians are reporting that they don’t have enough personal protective equipment behind the counter.

Recently, many providers have become worried about the potential of certain medications to worsen transmission and outcomes in the setting of the global COVID-19 pandemic.

Conferences such as the American Pharmacists Association (APhA) 2020 Annual Meeting and Expo are now implementing virtual versions of their programs.

Although vaccine development is underway, the process can take at least a year before reaching in the mass-production stage.

More than 10% of COVID-19 patients were infected by an asymptomatic person, according to new research.

Top news from across the health care landscape.

The goals of the expansion are to maintain social distancing and to avoid overburdening hospitals with patients.

Several pharmaceutical companies are racing to develop an effective treatment for the virus that is now a global pandemic.

A clinical program evaluating sarilumab (Kevzara, Sanofi and Regeneron) has started in patients hospitalized with a severe form of the novel coronavirus (COVID-19), according to the company.

The authorizations have been given to Hologic for its Panther Fusion SARS-CoV-2 Assay and to Laboratory Corporation of America for its COVID-19 reverse transcription polymerase chain reaction test.

A new executive order from Kentucky Gov. Andy Beshear has expanded prescribing rights to pharmacists in light of the novel coronavirus.

In an appeal to all Americans, Deborah Birx, MD, said everyone has a role in stopping COVID-19 from spreading.

The first clinical trial evaluating an investigational vaccine designed to protect against the novel coronavirus (COVID-19) has begun.

Protecting pharmacy staff is vital to ensuring continued care during the COVID-19 outbreak.

French health officials have warned that widely used OTC anti-inflammatory drugs may worsen the novel coronavirus known as COVID-19, whereas others say more evidence is needed.

In response to growing concern surrounding the novel coronavirus, Cedarville University School of Pharmacy and Cedar Care Village Pharmacy presented an online town hall meeting with an infectious disease expert.

Pharmacies across the country also taking necessary steps to help facilitate COVID-19 testing and to keep patients safe.

Top news from across the health care landscape.

The new guidance for industry (GFI) document, “Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products,” was released Saturday.